These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22814221)

  • 1. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics.
    Cai W; Deng W; Yang H; Chen X; Jin F
    Int J Pharm; 2012 Oct; 436(1-2):536-44. PubMed ID: 22814221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of an alternative triglyceride-free propofol microemulsion.
    Cho J; Cho JC; Lee P; Lee M; Oh E
    Arch Pharm Res; 2010 Sep; 33(9):1375-87. PubMed ID: 20945136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol.
    Li G; Fan Y; Li X; Wang X; Li Y; Liu Y; Li M
    Int J Pharm; 2012 Apr; 425(1-2):53-61. PubMed ID: 22266535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats.
    Lee EH; Lee SH; Park DY; Ki KH; Lee EK; Lee DH; Noh GJ
    Anesthesiology; 2008 Sep; 109(3):436-47. PubMed ID: 18719441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of pharmacokinetic and pharmacodynamic models of microemulsion and long-chain triglyceride emulsion propofol in beagle dogs.
    Lee SH; Park HW; Kim MJ; Noh MH; Yoon HS; Choi BM; Lee EK; Noh GJ
    J Vet Pharmacol Ther; 2012 Aug; 35(4):329-41. PubMed ID: 21790660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical properties and stability of two emulsion formulations of propofol.
    Han J; Davis SS; Washington C
    Int J Pharm; 2001 Mar; 215(1-2):207-20. PubMed ID: 11250106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of propofol-loaded microemulsion systems for parenteral delivery.
    Ryoo HK; Park CW; Chi SC; Park ES
    Arch Pharm Res; 2005 Dec; 28(12):1400-4. PubMed ID: 16392675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery.
    Damitz R; Chauhan A
    Int J Pharm; 2015; 486(1-2):232-41. PubMed ID: 25839419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high (5%) and low (1%) concentrations of micellar microemulsion propofol formulations with a standard (1%) lipid emulsion in horses.
    Boscan P; Steffey EP; Farver TB; Mama KR; Huang NJ; Harris SB
    Am J Vet Res; 2006 Sep; 67(9):1476-83. PubMed ID: 16948589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution.
    Wei L; Marasini N; Li G; Yong CS; Kim JO; Quan Q
    Int J Pharm; 2012 Nov; 437(1-2):203-12. PubMed ID: 22944305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.
    Lee SH; Ghim JL; Song MH; Choi HG; Choi BM; Lee HM; Lee EK; Roh YJ; Noh GJ
    Br J Pharmacol; 2009 Dec; 158(8):1982-95. PubMed ID: 19925493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
    Kim KM; Choi BM; Park SW; Lee SH; Christensen LV; Zhou J; Yoo BH; Shin HW; Bae KS; Kern SE; Kang SH; Noh GJ
    Anesthesiology; 2007 May; 106(5):924-34. PubMed ID: 17457123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthetic properties of a propofol microemulsion in dogs.
    Morey TE; Modell JH; Shekhawat D; Shah DO; Klatt B; Thomas GP; Kero FA; Booth MM; Dennis DM
    Anesth Analg; 2006 Oct; 103(4):882-7. PubMed ID: 17000798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness, safety, and pharmacokinetic and pharmacodynamic characteristics of microemulsion propofol in patients undergoing elective surgery under total intravenous anaesthesia.
    Jung JA; Choi BM; Cho SH; Choe SM; Ghim JL; Lee HM; Roh YJ; Noh GJ
    Br J Anaesth; 2010 May; 104(5):563-76. PubMed ID: 20299348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Micro to macro (M2M)"--A novel approach for intravenous delivery of propofol.
    Damitz R; Chauhan A
    Int J Pharm; 2015 Oct; 494(1):218-26. PubMed ID: 26260228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of non-lipid nanoemulsion of propofol with solutol and propofol emulsion with lecithin.
    Rodrigues TA; Alexandrino RA; Kanczuk ME; Gozzani JL; Mathias LA
    Rev Bras Anestesiol; 2012; 62(3):325-34. PubMed ID: 22656678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a new formulation of propofol in a medium-chain and long-chain triglycerides emulsion in dogs.
    Redondo García JI
    J Vet Pharmacol Ther; 2007 Aug; 30(4):288-94. PubMed ID: 17610401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative canine pharmacokinetics-pharmacodynamics of fospropofol disodium injection, propofol emulsion, and cyclodextrin-enabled propofol solution following bolus parenteral administration.
    McIntosh MP; Rajewski RA
    J Pharm Sci; 2012 Sep; 101(9):3547-52. PubMed ID: 22581759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of the effect of in-line 1.2 micron filters on two formulations of propofol (2,6-diisopropyl phenol).
    Kennedy RA; Kennedy ML; Morrissey H; Ball PA
    PDA J Pharm Sci Technol; 2015; 69(2):297-306. PubMed ID: 25868995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
    Nemec K; Germ E; Schulz-Siegmund M; Ortner A
    Pharmazie; 2009 Feb; 64(2):94-7. PubMed ID: 19320281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.